| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 7d-cis |
| PharmacoGx | Compound 7d-cis |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
| mRNA | FSD1 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-11 |
| mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | BRSK1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-11 |
| mRNA | SULT4A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-11 |
| mRNA | SALL2 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | RP11-463C8.4 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
